|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
[Clinical significance of the relationship between expression of survivin and effects of neoadjuvant chemotherapy in locally advanced breast cancer].
|
18701842 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
|
17170079 |
2006 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
|
18451232 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells.
|
18242580 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
|
15569667 |
2005 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In addition, BIRC5 expression may induce breast tumor proliferation by promoting genetic instability.
|
18181175 |
2008 |
|
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
|
17393113 |
2007 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
|
15611790 |
2005 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
|
18593928 |
2008 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
|
16026775 |
2005 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
|
16818634 |
2006 |
|
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Distinct expression of Survivin splice variants in breast carcinomas.
|
16142334 |
2005 |
|
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
|
16322251 |
2005 |
|
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
|
16873289 |
2006 |
|
Lung Neoplasms
|
0.390 |
AlteredExpression
|
group |
LHGDN |
Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer.
|
18708766 |
2008 |
|
Lung Neoplasms
|
0.390 |
AlteredExpression
|
group |
LHGDN |
The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
|
18192073 |
2008 |
|
Lung Neoplasms
|
0.390 |
Biomarker
|
group |
LHGDN |
Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells.
|
18652770 |
2008 |
|
Lung Neoplasms
|
0.390 |
Biomarker
|
group |
CTD_human |
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.
|
15981204 |
2005 |
|
Lung Neoplasms
|
0.390 |
AlteredExpression
|
group |
LHGDN |
Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
|
18630507 |
2008 |
|
Lung Neoplasms
|
0.390 |
Biomarker
|
group |
LHGDN |
Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.
|
18824294 |
2009 |
|
Lung Neoplasms
|
0.390 |
AlteredExpression
|
group |
LHGDN |
Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
|
17548900 |
2007 |
|
Lung Neoplasms
|
0.390 |
Biomarker
|
group |
CTD_human |
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
|
16108013 |
2006 |
|
Lung Neoplasms
|
0.390 |
AlteredExpression
|
group |
LHGDN |
Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy.
|
15829330 |
2005 |
|
Lung Neoplasms
|
0.390 |
Biomarker
|
group |
LHGDN |
COX-2-dependent stabilization of survivin in non-small cell lung cancer.
|
14597555 |
2004 |
|
Lung Neoplasms
|
0.390 |
Therapeutic
|
group |
CTD_human |
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
|
16108013 |
2006 |